SGLT2i Top DPP-4i for Survival in Diabetic Kidney Disease

Results from a large target trial emulation study reflect benefits in older patients up to age 80.
Medscape Medical News

Source link : https://www.medscape.com/viewarticle/sglt2-inhibitor-top-dpp-4-inhibitor-survival-diabetic-kidney-2026a100058w?src=rss

Author :

Publish date : 2026-02-19 11:04:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30

SGLT2i Top DPP-4i for Survival in Diabetic Kidney Disease

Which Salvage Therapy Is Best for Recurrent Prostate Cancer?

Is our galaxy’s black hole actually made of dark matter?

Related Posts

New CDC Messaging May Be Eroding Trust in Vaccines, Survey Finds

Why Can’t Europe Kick Its Antibiotic Habit?

New AI Model Beats Doctors at Clinical Reasoning, Diagnosis

‘We felt we had to miscarry again to get the help we needed’

FDA Panel Gives Thumbs Down to Novel Strategy for Switching Breast Cancer Therapy

Can Antihistamines Help Women With PMDD?

New CDC Messaging May Be Eroding Trust in Vaccines, Survey Finds

Why Can’t Europe Kick Its Antibiotic Habit?

New AI Model Beats Doctors at Clinical Reasoning, Diagnosis

‘We felt we had to miscarry again to get the help we needed’

FDA Panel Gives Thumbs Down to Novel Strategy for Switching Breast Cancer Therapy

Can Antihistamines Help Women With PMDD?

Noninvasive Tests Key to Identifying MASH in Primary Care

IBD Drugs and Heart Attacks; AI Finds Occult Pancreatic Cancer; Managing Hemorrhoids

Categories

Archives